GlassScriptPhysician profile
Sherif Hanna
NPI 1467415695
$6,858.86
in general payments reported to CMS, 2019-2025
47 companies · $1,134 in 2025
The $1,134 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,848 · 2020: $347 · 2021: $325 · 2022: $305 · 2023: $1,428 · 2024: $1,473 · 2025: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,014 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,014.09 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,141.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $878.22 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $627.85 | 2019-2025 | |
| Abbott Laboratories | $431.10 | 2019-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $418.23 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $387.59 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Astellas Pharma US INC | $329.33 | 2019-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $254.97 | 2019-2025 | Ofev, Jardiance |
| Amarin Pharma, INC. | $239.25 | 2019-2022 | |
| Amgen INC. | $137.40 | 2019-2025 | Prolia, Evenity, Otezla |
| Eisai INC. | $121.74 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $120.96 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.88 | 2019-2024 | Xifaxan, Trulance |
| Dexcom, INC. | $113.22 | 2023-2025 | Dexcom G6 Transmitter |
| Allergan, INC. | $103.36 | 2019-2020 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $93.10 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $92.76 | 2021-2024 | Eliquis |
| Shield Therapeutics INC | $88.76 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.62 | 2024 | |
| Abbvie INC. | $85.42 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $85.34 | 2019-2024 | Dificid, Gardasil 9, Gardasil |
| Dynavax Technologies Corporation | $80.94 | 2024-2025 | Heplisav-B |
| Xeris Pharmaceuticals, INC. | $79.33 | 2023-2024 | Gvoke Hypopen |
| Optinose US, INC. | $70.10 | 2021-2024 | |
| Kowa Pharmaceuticals America, INC. | $63.58 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.28 | 2019-2023 | Vpriv |
| Idorsia Pharmaceuticals US INC | $53.09 | 2023 | Quviviq |
| Sumitomo Pharma America, INC. | $49.94 | 2023-2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $48.49 | 2019-2023 | Xarelto |
| Nalpropion Pharmaceuticals LLC | $36.37 | 2019 | |
| Sanofi Pasteur INC. | $35.77 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $30.38 | 2019 | |
| Genentech USA, INC. | $28.61 | 2020 | |
| Inari Medical, INC. | $27.05 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $25.53 | 2020-2023 | |
| Seqirus USA INC | $24.43 | 2025 | Fluad, Flucelvax |
| Antares Pharma, INC. | $23.66 | 2019-2021 | |
| Aimmune Therapeutics, INC. | $21.94 | 2024 | |
| Gilead Sciences, INC. | $21.24 | 2025 | |
| Medtronic, INC. | $21.13 | 2025 | Symplicity G3 |
| Lundbeck LLC | $18.07 | 2023 | Rexulti |
| Inspire Medical Systems, INC. | $17.89 | 2024 | Inspire |
| Sunovion Pharmaceuticals INC. | $17.73 | 2021 | |
| Ethicon US, LLC | $15.03 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.55 | 2019 | |
| Neuronetics, INC. | $12.25 | 2019 | |
| Avanir Pharmaceuticals, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherif Hanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.